MyFinsight
Home
Blog
About
Net income
$42,987K
(-22.82%↓ Y/Y)
Accrued and other
liabilities, current and...
$34,315K
(571816.67%↑ Y/Y)
Stock-based compensation
$29,416K
(-28.00%↓ Y/Y)
Deferred income taxes
$2,881K
(109.16%↑ Y/Y)
Depreciation and
amortization
$863K
(51.14%↑ Y/Y)
Net cash provided by
operating activities
$33,543K
(-31.64%↓ Y/Y)
Net effect of
exchange rate changes on...
$37K
(-97.94%↓ Y/Y)
Canceled cashflow
$76,919K
Net decrease in
cash, cash...
$2,301K
(109.23%↑ Y/Y)
Canceled cashflow
$31,279K
Trade receivables
$37,848K
(257.36%↑ Y/Y)
Accounts payable
-$18,241K
(-323.84%↓ Y/Y)
Accrued research and
development expenses
-$12,463K
(-158.62%↓ Y/Y)
Inventory
$4,264K
(6.04%↑ Y/Y)
Prepaid expenses and
other current assets
$3,396K
(52.15%↑ Y/Y)
Accretion of marketable
securities, net
-$707K
(76.47%↑ Y/Y)
Proceeds from sales and
maturities of marketable...
$62,241K
(-69.72%↓ Y/Y)
Proceeds from stock
option exercises, net...
$5,757K
(-47.54%↓ Y/Y)
Proceeds from purchases
under the employee...
$3,663K
(-26.59%↓ Y/Y)
Net cash (used in)
provided by investing...
-$29,242K
(-143.67%↓ Y/Y)
Net cash used in
financing activities
-$2,037K
(98.57%↑ Y/Y)
Canceled cashflow
$62,241K
Canceled cashflow
$9,420K
Purchases of marketable
securities
$88,955K
(-35.73%↓ Y/Y)
Cash paid to satisfy
statutory withholding...
$11,457K
(-59.45%↓ Y/Y)
Purchases of property and
equipment
$2,528K
(1470.19%↑ Y/Y)
Back
Back
Cash Flow
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)
source: myfinsight.com